STOCK TITAN

Healwell AI Inc. - $HWAIF STOCK NEWS

Welcome to our dedicated page for Healwell AI news (Ticker: $HWAIF), a resource for investors and traders seeking the latest updates and insights on Healwell AI stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Healwell AI's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Healwell AI's position in the market.

Rhea-AI Summary

HEALWELL AI announced its agreement to acquire VeroSource Solutions, a Canadian company specializing in healthcare data interoperability, for $24.5 million. The acquisition will be completed in two stages: an initial 51% share purchase for $12.5 million by July 1, 2024, and the remaining shares by January 1, 2025. VeroSource, serving five provincial health clients, is expected to generate over $8 million in revenue in 2024, with an EBITDA margin exceeding 10%. The acquisition aims to enhance HEALWELL’s AI capabilities, integrating VeroSource's platform to boost data management and early disease detection efforts.

VeroSource has demonstrated strong performance with a 3-year revenue CAGR of 30%, over 80% gross margins, and a high proportion of recurring revenue. The acquisition will be strategically accretive, leveraging VeroSource’s technology and client base to expand HEALWELL’s footprint in the healthcare sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.41%
Tags
-
Rhea-AI Summary

HEALWELL AI's subsidiary, Pentavere, announces a partnership with Takeda to enhance real-world evidence analysis for patients with hereditary angioedema (HAE) having normal C1 inhibitor. This collaboration has generated one of the largest global datasets for HAE patients, aiming to improve clinical outcomes. The initiative builds on Pentavere's win in the Takeda Canada Innovation Challenge 2022. The Canadian Organization of Rare Disorders praises this partnership for its potential to revolutionize rare disease diagnosis and care in Canada. A manuscript and an abstract on the dataset are in preparation for publication.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.72%
Tags
partnership AI
-
Rhea-AI Summary

HEALWELL AI has appointed Anthony Lam as its new Chief Financial Officer (CFO), effective immediately. Lam brings over 20 years of senior finance and operational leadership experience in various technology sectors and will report directly to CEO Dr. Alexander Dobranowski.

Lam succeeds Scott Nirenberski, who served as CFO since September 2020. Lam's previous roles include CFO at eSentire and Newtopia, with a background in analytics, treasury, and capital markets.

Dr. Dobranowski expressed confidence in Lam's ability to drive HEALWELL's next growth phase. Lam aims to enhance financial discipline and leverage technology for efficiency. The company focuses on preventative care using AI and data science.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.08%
Tags
management AI
Rhea-AI Summary

HEALWELL AI, trading under the symbol HWAIF, announced a partnership between its subsidiary Pentavere and Sunnybrook Health Sciences Centre, led by Dr. Tony Eskander, to enhance cancer staging using the DARWEN™ AI platform.

This collaboration demonstrated the AI's capability to improve the accuracy and speed of cancer staging, which is important for head and neck cancers, and was published in JAMA Otolaryngology.

The study showcased AI's potential to analyze unstructured clinical text within electronic health records, supporting clinical decision-making and improving patient outcomes.

The findings suggest that Pentavere's AI could revolutionize oncological care by providing clinicians with timely and accurate cancer staging, thus optimizing treatment decisions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.55%
Tags
partnership AI
-
Rhea-AI Summary

HEALWELL AI announced its participation in leading-edge research on Chronic Kidney Disease (CKD). Their Clinical Co-Pilot technology, integrated with a machine model for CKD progression, enhances guideline-recommended testing when paired with EHR-linked clinical decision support. An abstract co-authored by HEALWELL's subsidiary, Khure Health, was published in the American Journal of Kidney Diseases. The research highlights the utility of HEALWELL’s AI technology in improving CKD patient care. CKD is a significant health issue, affecting one-seventh of the North American population and costing Canada over $40 billion annually. Recently, WELL Health Technologies launched its second-generation AI Co-Pilot, powered by HEALWELL, now available to thousands of providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI reported significant growth in Q1-2024, with revenue from continuing operations reaching $4.58 million, a 132% increase compared to $1.97 million in Q1-2023.

This growth is primarily attributed to the acquisition of Intrahealth on February 1, 2024. The company’s revenue run-rate has more than doubled to over $20 million, with SaaS and services forming the largest component.

The management projects potential to more than double the annual revenue to over $40 million with existing cash reserves. HEALWELL closed Q1-2024 with $11.3 million in cash, and an additional $20 million financing deal is expected to further strengthen its financial position.

Despite positive revenue growth, the company posted an adjusted EBITDA loss of $2.56 million. HEALWELL’s strategic alliance with WELL Health Technologies continues to flourish with new AI-driven tools for chronic disease detection.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.34%
Tags
Rhea-AI Summary

HEALWELL AI Inc. will announce its Fiscal First Quarter 2024 financial results on May 14, 2024. The company focuses on preventative care and will hold a conference call and webcast to discuss the results, hosted by CEO Dr. Alexander Dobranowski and CFO Scott Nirenberski.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.03%
Tags
-
Rhea-AI Summary

WELL and HEALWELL AI have launched the second-generation WELL AI Decision Support (WAIDS) with advanced chronic disease screening capabilities, aiding in patient risk stratification. The tool identifies over 100 diseases, providing actionable insights at the point of care. Chronic diseases affect 45.1% of Canadians, costing the economy $190 billion annually.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.02%
Tags
AI
-
Rhea-AI Summary
HEALWELL AI Inc. announces its subsidiaries, Khure Health & Pentavere Research Group, will present at major medical conferences in May 2024. Khure Health will showcase AI clinical decision support technology at the National Kidney Foundation Spring Clinical Meetings, while Pentavere will present AI research at various conferences. The conferences include the Canadian Retina Society Annual Meeting, American Head & Neck Society Annual Meeting, and American Medical Informatics Association Clinical Informatics Conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.21%
Tags
conferences
Rhea-AI Summary
Nvidia's focus on healthcare and AI showcases market interest in the intersection of these fields. HEALWELL AI Inc. (HWAIF) emerges as a key player in AI-driven preventative care solutions, with a revenue of $2.8 million in Q3-2023. Recent commercial agreements with WELL Health USA and Circle Medical signal significant growth opportunities for HEALWELL in the U.S. market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.29%
Tags
none
Healwell AI Inc.

OTC:HWAIF

HWAIF Rankings

HWAIF Stock Data

183.82M
84.75M
52.45%
1.66%
Offices of Physicians (except Mental Health Specialists)
Health Care and Social Assistance
Link
United States of America
Toronto